Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Apply
Repotrectinib
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step